Cancer surgeons should continue to use their oncologic knowledge to determine the window of opportunity for each surgical procedure, based on tumor biology, preoperative treatment sequencing, and response to systemic therapy, to safely guide patients through this cautious recovery phase.
Oncologists may be key in ensuring patients with cancer safely receive vaccinations and avert avoidable infections.
A touching moment at the 2024 Oscars saw Sean Ono Lennon pick up a prize and pay tribute to his mother Yoko.
Despite the successes of immunotherapy in cancer treatment over recent decades, less than <10%–20% cancer cases have demonstrated durable responses fr…
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.
Despite the remarkable success of anti-cancer immunotherapy, its effectiveness remains confined to a subset of patients—emphasizing the importance of …
Important advances are coming our way in the next 5-10 years.
Immunohistochemistry (IHC) is currently the first-line test for mismatch repair deficiency (MMR-D). Bou Farhat et al. show that mismatch repair (MMR) mutation signature by next-generation sequencing…
Rectal cancer in the United States is increasingly being managed without the use of surgery, leading to higher rates of organ preservation.
